Matrix Gla Protein (MGP) (Middle Region) Peptid
Kurzübersicht für Matrix Gla Protein (MGP) (Middle Region) Peptid (ABIN8104915)
Target
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- MGP Peptide - middle region
-
-
Matrix Gla Protein (MGP) (AA 20-96) peptide (His tag)
MGP Reaktivität: Human Wirt: Escherichia coli (E. coli) SDS
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-MGP antibody ( ARP51308_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- MGP (Matrix Gla Protein (MGP))
-
Hintergrund
-
Background Information: MGP is associates with the organic matrix of bone and cartilage. MGP is thought to act as an inhibitor of bone formation.
Alternative Symbols: GIG36, MGLAP, NTI
-
Molekulargewicht
- 12kDa
-
Gen-ID
- 4256
-
NCBI Accession
- NP_000891
-
UniProt
- P08493
Target
-
